Table 1.
Susceptibility data and Fks1p and Fks2p phenotypes for the three C. glabrata isolates used in animal experimentsa
| Strain | Fks alteration | Microdilution MIC (μg/ml)c | CLSI disk diffusion zone diam (mm) for: | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EUCAST | CLSI | EUCAST-BSAb | CLSI-BSA | ||||||||||||
| ANF | CSF | MCF | ANF | CSF | MCF | ANF | CSF | MCF | ANF | CSF | MCF | CSF | MCF | ||
| S3 | None | ≤0.03 | 0.25 | ≤0.03 | 0.031 | 0.031 | 0.125 | 1 | 0.25 | 1 | 1 | 0.25 | 1 | 31.8 | 31.0 | 
| ≤0.03 | 0.25 | ≤0.03 | 0.25 | 0.125 | 0.064 | 1 | 0.25 | 2 | |||||||
| 0.06 | 0.25 | ≤0.03 | 0.25 | 0.125 | 0.064 | 1 | 0.5 | 1 | |||||||
| (≤0.042) | (0.25) | (≤0.03) | (0.177) | (0.094) | (0.083) | (1) | (0.333) | (1.333) | |||||||
| R83 | Fks2p-S663F | 0.5 | 1 | 0.06 | 0.25 | 0.125 | 0.25 | ≥32 | ≥32 | ≥32 | 4 | 4 | 8 | 19.5 | 22.1 | 
| 0.5 | 1 | ≤0.03 | 1 | 1 | 1 | ≥32 | ≥32 | ≥32 | |||||||
| 0.25 | 1 | ≤0.03 | 2 | 1 | 0.5 | 8 | 4 | 16 | |||||||
| (1.083) | (1) | (≤0.042) | (1.083) | (0.708) | (0.583) | (≥24) | (≥22.67) | (≥26.67) | |||||||
| RR24 | Fks1p-S629P | 4 | 16 | 1 | 4 | 8 | 4 | ≥32 | ≥32 | ≥32 | ≥32 | ≥32 | ≥32 | 17.8 | 20.0 | 
| 4 | 16 | 1 | 2 | 8 | 2 | ≥32 | ≥32 | ≥32 | |||||||
| 2 | ≥32 | 2 | 4 | 8 | 2 | ≥32 | ≥32 | ≥32 | |||||||
| (3.333) | (≥21.333) | (1.333) | (3.333) | (8) | (2.667) | (≥32) | (≥32) | (≥32) | |||||||
EUCAST, EUCAST-BSA, and CLSI tests were each done on three separate occasions, whereas a single run of CLSI-BSA and disk testing was performed.
BSA, bovine serum albumin-supplemented susceptibility test growth medium.
ANF, anidulafungin; CSF, caspofungin; MCF, micafungin. Mean MICs from the three testing occasions, in cases where three tests were administered, are given in parentheses.